In the microenvironment of many tumors, binding of T-cell PD-1 to PD-L1 on tumor cells, lymphocytes or macrophages inactivates CD8+ T cells, thereby protecting tumors from destruction by the immune system (2). This evidence concerns the gene PDCD1 and neoplasm.